The MarketReader Minute
💊 Exelixis Rises, Alnylam Gains While Novavax Inc Plunges After FDA Hold and AbbVie Inc Reaches a Nine-Week Low | Biotech Sector Insights
The FDA approved Novocure's Optune Lua for treating metastatic non-small cell lung cancer, marking an advancement in biotechnology treatment options. (WVE) reported an achievement in RNA medicine, successfully conducting the first therapeutic RNA editing in humans for alpha-1 antitrypsin deficiency.